Now showing items 1-5 of 5
Availability of WHO essential medicines for cancer treatment in Botswana
(American Society of Clinical Oncology, http://www.asco.org/, 2018-01-23)
Purpose Stock outs of cancer drugs are potentially fatal but have not been systematically studied in low- and middle-income countries. The aim of this study was to determine the availability and alignment of the Botswana ...
Botswana's HIV response: policies, context, and future directions
(Wiley, http://onlinelibrary.wiley.com/, 2020-01-17)
This brief report describes key periods in the history of the national public health response to the HIV epidemic in Botswana. It reveals the context leading to the development of HIV policies presently in place and current ...
HIV infection and survival among women with cervical cancer
(American Society of Clinical Oncology, https://beta.asco.org/, 2016-08-29)
Purpose Cervical cancer is the leading cause of cancer death among the 20 million women with HIV worldwide. We sought to determine whether HIV infection affected survival in women with invasive cervical cancer. Patients ...
Explaining disparities in oncology health systems delays and stage at diagnosis between men and women in Botswana: A cohort study
(Public Library of Science, http://www.plosone.org/, 2019-06-06)
Purpose Men in Botswana present with more advanced cancer than women, leading to poorer outcomes. We sought to explain sex-specific differences in time to and stage at treatment initiation. Methods Cancer patients who ...
Impact of human immunodeficiency virus infection on survival and acute toxicities from chemoradiation therapy for cervical cancer patients in a limited-resource setting
(Elsevier, https://www.elsevier.com/en-xm, 2018-05-01)
Purpose—To prospectively compare survival between human immunodeficiency virus (HIV)-infected versus HIV-uninfected cervical cancer patients who initiated curative chemoradiation therapy (CRT) in a limited-resource ...